Oracle Investment Management as of Sept. 30, 2018
Portfolio Holdings for Oracle Investment Management
Oracle Investment Management holds 16 positions in its portfolio as reported in the September 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Quidel Corporation | 35.2 | $136M | 2.1M | 65.17 | |
| Amarin Corporation (AMRN) | 24.7 | $95M | 5.9M | 16.27 | |
| Pacific Biosciences of California (PACB) | 13.3 | $51M | 9.4M | 5.41 | |
| Tesaro | 5.2 | $20M | 517k | 39.01 | |
| Accelr8 Technology | 4.1 | $16M | 5.2M | 3.09 | |
| Biolase | 3.3 | $13M | 6.2M | 2.07 | |
| Opko Health (OPK) | 3.3 | $13M | 3.7M | 3.46 | |
| Adaptimmune Therapeutics (ADAP) | 3.2 | $12M | 898k | 13.56 | |
| Contrafect | 2.3 | $8.8M | 4.3M | 2.07 | |
| Vermillion | 1.8 | $7.0M | 9.8M | 0.71 | |
| Soleno Therapeutics | 1.4 | $5.3M | 2.4M | 2.16 | |
| Agenus (AGEN) | 0.8 | $3.2M | 1.5M | 2.14 | |
| Biogen Idec (BIIB) | 0.6 | $2.3M | 6.4k | 353.33 | |
| Viewray (VRAYQ) | 0.5 | $2.0M | 217k | 9.36 | |
| Aduro Biotech | 0.2 | $820k | 112k | 7.35 | |
| Epizyme | 0.1 | $306k | 29k | 10.59 |
